-
Opinion: The Johnson & Johnson cancer drug scandal that encapsulates corruption in health care
03 Apr 2025 14:59 GMT
… interests of major pharmaceutical companies that largely … trials or made dose adjustments of the J&J epoetin … doctors and hospitals to expand the use of Procrit.
Lying to Medicare … not routine drug prescriptions. Since cancer treatments were usually …
-
Biosimilars Market Products, Applications and Regulations Overview 2025: Increasing Cost of Biologic Drugs, Leading to a Greater Demand for More Affordable Options - Global Forecasts 2024-2030 - ResearchAndMarkets.com
11 Mar 2025 13:32 GMT
… disorders (such as epoetin for treating anemia … pharmaceutical research and development, a rising demand for affordable treatments … Ltd
Hetero Drugs Limited
Intas Pharmaceuticals Ltd.
… Biotech, Inc.
STADA Arzneimittel AG
STgen Bio Co., Ltd.
Teva Pharmaceutical …
-
Global Epoetin Alfa Market Outlook 2025-2034: Growth Drivers, Share, And Trends
06 Mar 2025 23:13 GMT
… drug efficacy and delivery.
oIntroduction of innovative biologics, expanding treatment … landscape.
oProgress in medical technology, enhancing drug administration methods.
… and advancements in biotechnology.
How is the Epoetin Alfa Market Segmented …
-
Patient Access To Cheaper Biosimilar Drugs Varies Significantly Across Pharmacy Benefit Managers
05 Mar 2025 14:10 GMT
… who take the autoimmune disease treatment Humira now see some price … drug coverage for roughly 266 million Americans. Here, they determine which medications … entry, but in the immunology, epoetin alfa and insulin glargine spaces …
-
Innovation, AI, Trials and India: At the cusp of a global pharma and biotech reset
27 Feb 2025 07:44 GMT
… will help find new medical treatments.
These decisions renew … state of the Indian pharmaceutical/biotech industry. As the … identifying specific trial participants for an experimental drug that needed … not doing clinical trials, global companies have turned …
-
Yang Highlights Positive COMMANDS Trial Data for Luspatercept in MDS
20 Feb 2025 00:44 GMT
… University School of Medicine
Karmanos Cancer Institute
Detroit … 500, epoetin alfa [Procrit] or luspatercept are both reasonable treatment options … reported in both the trial and clinical experience. … open-label, randomised controlled trial. Lancet. 2023;402( …
-
Erythropoietin (EPO) Drugs Market Forecast To Surge USD 12.5 Billion By 2033, Driven By 5.20% CAGR
07 Feb 2025 09:58 GMT
… darbepoetin alfa and epoetin beta, offer … Treatment Plans: AI-driven algorithms analyze patient medical … necessitate extensive clinical trials and data, … Pharmaceuticals
•GlycoMimetics Inc.
•Akebia Therapeutics
Emerging Trends in Erythropoietin (EPO) Drugs …
-
Global Procrit Market Forecast: Key Growth Drivers, Trends, and Opportunities from 2025 to 2034
30 Jan 2025 17:28 GMT
… to minimally invasive treatments, growth in personalized medicine, increasing government investment … Inc. Their work with Procrit epoetin alfa—used to treat anemia … Distribution Channel: Direct Sales, Pharmaceutical Wholesalers, Retail Pharmacies
3 By …
-
Erythropoietin Drugs Market: Trends and Insights | CAGR of 5.7%
28 Jan 2025 07:06 GMT
… treatment costs and enhances market penetration.
Erythropoietin Drugs Market Segments:
By PRODUCTS:
Epoetin … Sciences Ltd.
Teva Pharmaceutical Industries Ltd.
Intas Pharmaceuticals
Ranbaxy Laboratories Ltd.,
Celltrion …
-
Treatment Inertia and Symptom Burden in Anemia of CKD: Insights from the SATISFY Survey in the Middle East, South Africa, and Türkiye
21 Jan 2025 18:11 GMT
… enrolled in a clinical trial were excluded.
Objectives
The … initiate treatment and the actual reported test levels from medical records … are not addressed in clinical trials, which only include patients … who are receiving hemodialysis and epoetin. N Engl J Med. …